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Abstract
Aims: The concealed phase of arrhythmogenic right ventricular cardiomyopathy (ARVC) may initially manifest
electrophysiologically. No studies have examined dynamic conduction/repolarization kinetics to distinguish benign right
ventricular outflow tract ectopy (RVOT ectopy) from ARVC’s early phase. We investigated dynamic endocardial
electrophysiological changes that differentiate early ARVC disease expression from RVOT ectopy.
Methods: 22 ARVC (12 definite based upon family history and mutation carrier status, 10 probable) patients without right
ventricular structural anomalies underwent high-density non-contact mapping of the right ventricle. These were compared
to data from 14 RVOT ectopy and 12 patients with supraventricular tachycardias and normal hearts. Endocardial & surface
ECG conduction and repolarization parameters were assessed during a standard S1-S2 restitution protocol.
Results: Definite ARVC without RV structural disease could not be clearly distinguished from RVOT ectopy during sinus
rhythm or during steady state pacing. Delay in Activation Times at coupling intervals just above the ventricular effective
refractory period (VERP) increased in definite ARVC (43620 ms) more than RVOT ectopy patients (36614 ms, p = 0.03) or
Normals (25616 ms, p = 0.008) and a progressive separation of the repolarisation time curves between groups existed.
Repolarization time increases in the RVOT were also greatest in ARVC (definite ARVC: 18620 ms; RVOT ectopy: 5614,
Normal: 1618, p,0.05). Surface ECG correlates of these intracardiac measurements demonstrated an increase of greater
than 48 ms in stimulus to surface ECG J-point pre-ERP versus steady state, with an 88% specificity and 68% sensitivity in
distinguishing definite ARVC from the other groups. This technique could not distinguish patients with genetic
predisposition to ARVC only (probable ARVC) from controls.
Conclusions: Significant changes in dynamic conduction and repolarization are apparent in early ARVC before detectable
RV structural abnormalities, and were present to a lesser degree in probable ARVC patients. Investigation of dynamic
electrophysiological parameters may be useful to identify concealed ARVC in patients without disease pedigrees by using
endocardial electrogram or paced ECG parameters.
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Introduction
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is
a disease of cardiomyocyte adhesion; initial myocyte slippage and
loss of gap junction integrity is followed by more overt structural
changes, with characteristic fibrofatty replacement of cardiomyo-
cytes[1]. These early manifestations of ARVC pose an important
diagnostic challenge, especially in differentiating benign outflow
tract ventricular ectopy from ARVC, as sudden death may occur
in the concealed phase before structural changes appear and an
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early manifestation may simply be right ventricular (RV)
ectopy[2,3].
Pre-clinical work has highlighted putative mechanisms by which
arrhythmias in ARVC may occur. Genetically modified mice
deficient in plakophilin-2 exhibit slow conduction in the absence of
significant histological anomalies and heterozygous desmoplakin
knock out mice have impaired conduction reserve [4–6]. The
association of the cardiac sodium channel with the desmosome as
a functional unit has been proposed as a mechanism by which
these electrophysiological changes may arise without conventional
histological structural changes [7]. Furthermore, abnormalities in
myocyte lineage determination may arise from interactions
between mutant transcripts in ARVC and cell fate pathways [8].
Thus several elegant pathogenic mechanisms have been proposed
that can explain early arrhythmias in ARVC without overt
structural disease.
To date, clinical studies on the electrophysiology of patients
with ARVC have overwhelmingly concentrated on patients with
established ventricular macroscopic structural markers as a
principle feature of their disease. These studies have demonstrated
that patients with ARVC exhibit slow conduction within the right
ventricle and low endocardial bipolar voltages, indicative of
endocardial fibrosis[9,10]. Whether dynamic conduction slowing
is an important distinguishing feature of human disease in the
absence of structural anomalies remains to be fully explored.
We have demonstrated significant dynamic conduction and
repolarization differences between desmoplakin mutation carriers
and controls, but there has been no direct comparison of the
dynamic electrophysiological changes in early ARVC versus
patients with outflow tract ectopy (RVOT ectopy)[6]. This is an
important clinical issue as ARVC patients may initially present
with isolated outflow tract ectopy. In this study we specifically
investigated a population including patients who qualify as
‘‘definite ARVC’’ in the modified Task Force Criteria only because
of a definite family history/mutation carrier status without evidence of
significant structural disease such that they have earlier/milder disease
than customarily reported in ARVC. Patients with benign RV
outflow tract ectopy (RVOT ectopy) can be viewed as an
important control population as they may be expected to exhibit
secondary features & adaptations associated with frequent ectopy.
Differentiation between ARVC and RVOT ectopy groups will
highlight salient disease features rather than merely adaptations to
ectopy.
We hypothesized that patients with early ARVC would exhibit
slowing of conduction & repolarization changes compared to
RVOT ectopy patients under conditions of electrical stress, even
prior to detectable structural disease. Furthermore, we hypothe-
sized these myocardial electrophysiological changes would man-
ifest on the surface ECG which ultimately may be of value in the
development of a diagnostic test.
Methods
Ethics statement
The research was approved by University College London
Hospitals Ethics Committee A (08/H0714/97), prior written
informed consent to participate in this study was obtained from all
participants.
Patient selection
Patients aged 18–65 years with definite or probable ARVC by
modified task force criteria (including familial or genetic criteria)
were prospectively recruited to participate in the study and
informed consent was obtained. All patients underwent detailed
imaging assessment including echocardiography/MRI and were
only included in this study if they did not have major imaging
criteria for ARVC (i.e.: severe RV dilatation, RV aneurysms,
severe segmental RV dilatation)[11]. Different aspects of the
electrophysiology of the patients who carry desmoplakin mutations
have been published elsewhere[6]. Benign right ventricular
outflow tract ectopy (RVOT ectopy group) or supraventricular
tachycardia patients (Normal group) were compared. The RVOT
ectopy group had normal resting and signal averaged ECGs, only
unifocal ectopy, structurally normal hearts on echocardiogram/
CMR and no family history of sudden cardiac death. All
supraventricular tachycardia control patients had normal resting
ECGs and normal echocardiograms. In order to minimize the
likelihood of a patient with their first presentation of hitherto
clinically silent ARVC being misassigned a diagnosis of benign
RVOT ectopy, RVOT ectopy patients were excluded if they had a
recurrence of ventricular ectopy/tachycardia post ablation, all
patients had at least 18 months of follow up.
Genetic testing
10 ml whole blood samples were obtained from ARVC patients
and family members. Genomic DNA was extracted using a
commercially available DNA extraction kit (QIAamp DNA Blood
mini kit, Qiagen). Index cases were part of a larger patient cohort
comprehensively screened for mutations in desmoplakin, plako-
globin, plakophilin-2, desmoglein-2 and desmocollin-2. Primer
pairs for DSP exons were designed in flanking intronic sequences
and are available on request. Polymerase chain reaction (PCR)
amplification and direct sequencing on an ABI 3130 Genetic
Analyzer were performed using standard protocols as previously
described [12-14]. A total of 300 unrelated healthy, ethnically
matched Caucasian volunteers served as controls.
Electrophysiological mapping
The procedure for non-contact mapping has been previously
described in detail elsewhere [15–17]. In brief, the non-contact
array (St Jude Medical, USA) was placed in the right ventricular
outflow tract via the left femoral vein under conscious sedation.
The non-contact array consists of a basket catheter containing 64
electrodes which is placed within a cardiac chamber. Changes in
relative electrode impedance are used to sense the 3D relative
positions of a separate roving catheter, and in this way a 3D
representation of the chamber endocardial geometry is created.
The Ensite system then employs an inverse-Laplacian solution to
the field electrograms, sensed by the array and calculates ‘‘virtual’’
unipolar electrograms over the entire endocardial geometrical
surface. It thus reconstructs the electrical activity on the wall at any
user-designated point. The geometry of the right ventricular
endocardium was created with a steerable quadrapolar mapping
or ablation catheter. Programmed ventricular stimulation was
performed from the right ventricular apex. 3 minutes of steady
state pacing at 400 ms coupling intervals was followed by a S1S2
restitution protocol. This protocol consisted of performing 8 beat
trains of pulses (S1) at 400 ms coupling intervals followed by a
single, premature stimulus (S2). The S1S2 coupling interval was
reduced sequentially from 400 ms by 20 ms until 300 ms, then by
5 ms intervals until failure to elicit a ventricular response
(refractoriness) was reached. The S1S2 interval was increased by
8 ms and then further reduced by 2 ms steps to establish the
Ventricular Effective Refractory Period (VERP) and proximal end
of the restitution curve. Two-second intervals were left between
trains. 12 lead electrocardiograms were recorded throughout the
procedure.
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Offline analyses
Analysis of electrograms. 24 ‘‘virtual’’ unipolar electro-
grams were placed in 4 columns of 6 across the RV chamber on
the Ensite console. Global data was thus acquired from the entire
geometry (Figure 1) and good spatial resolution achieved without
giving overwhelming quantities of data. Electrograms were
exported and analysed using semi-automated custom software
running in Matlab (The Mathworks Inc., MA, USA). Activation
recovery interval (ARI), a well-validated approximation of action
potential duration, was defined as the time between AT and
repolarization time and measured as previously described
(Figure 2) [18]. The slope of ARI restitution was calculated using
the least mean squares method [19]. All electrograms, and the
results of semi-automated analyses, were manually checked by MF
& AA, who were blinded to clinical diagnosis at the time of signal
analysis. Reproducibility of electrogram analysis results were
confirmed by repeating analyses, with intra-operator variability
(Cronbach’s alpha) 0.95 for repolarization and 0.96 for activation
time measurements.
In sinus rhythm, the time from the earliest electrogram recorded
within the right ventricle (RV) to the steepest negative deflection
(dV/dtmin) was used as the local activation time (AT, figure 1). The
sinus rhythm AT of the RV was taken as the time from earliest to
latest recorded RV activation. During pacing, the time from
pacing artifact to dV/dtmin was used as the local AT.
Two methods have been used to measure repolarization times
during non-contact mapping, termed the classical (Wyatt) method
and the alternative method. Both have come under intense
theoretical and experimental scrutiny, and here we present results
using the classical method [20–23]. Though numerical values
differed between the two methods, overall results are similar[18].
Activation repolarization interval (ARI), a well-validated approx-
imation of action potential duration, was defined as the time
between AT and repolarization time and measured as previously
described (figure 2). The slope of ARI restitution was calculated
using the least mean squares method. The RV was divided into 16
anatomic segments, activation and repolarization dynamics were
studied in the apex, RV body and outflow tract [19].
Fractionation of activation was determined by counting the
number of deflections in the differential of the unipolar
electrogram [6,17]. A 30-250Hz filter removed low and high-
frequency interference, and a signal-to-noise ratio cutoff of 0.4Hz
was applied prior to counting. Analysis was performed in sinus
rhythm, steady state pacing and following premature stimulus
2 ms above the ventricular effective refractory period (pre-VERP).
Endocardial regional delay and endocardial local
activation delay. Mean Increase of Delay is a convenient
surrogate measure of conduction velocity restitution. In brief, the
activation time is plotted against coupling interval during a
restitution curve pacing sequence. Mean Increase in Delay refers
to the mean increase in activation time as the coupling interval is
reduced to ERP, and is expressed as millisecond increase in delay
per millisecond reduction in coupling interval (ms/ms). This was
calculated as previously described [6,17,24]. Areas of local
Figure 1. Sinus rhythm electrogram analysis (A) and 3D virtual electrode locations on reconstructed RV shell (B). A) Activation time in
sinus rhythm is taken from the earliest discernable ventricular activation (i.e. start of QRS complex) in any lead, and is measured to the local activation
from the unipolar electrogram (most negative dV/dt, red circle). Local repolarization is given as the sharpest upstroke of the T wave, as with paced
measurements. Time for activation of the RV is thus calculated as the difference between the local AT of the earliest activating electrode (ATearly) to
the local AT of the latest activating electrode (ATlate). B) Virtual electrodes were placed in four rows corresponding to anterior, lateral, medial and
posterior aspects of the RV. They thus covered apex (8 electrodes, 4 segments), outflow tract (8 electrodes, 4 segments) and mid-ventricle (8
electrodes, 8 segments). This enabled global electrograms to be collected without overwhelming quantities of data.
doi:10.1371/journal.pone.0099125.g001
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activation delay during sinus rhythm were determined using
activation gradient quantification as previously described [25].
This technique uses an automated algorithm to calculate of the
slowest progression of an activation wavefront through the cardiac
chamber, and the consistency in the activation wavefront
propagation is expressed as a linear determinant r2 (the closer
the value to 1, the greater the beat to beat consistency).
Paced surface electrocardiogram (ECG) analysis. 12-
lead ECGs were recorded simultaneously during the S1-S2
protocol. Signals were filtered with bandpass settings of 0.1 –
50Hz. Measurements were performed manually using on-screen
calipers at 200 mm/sec (MF & AS) blinded to the patient
diagnosis. Timings were measured from the pacing stimulus to a)
the earliest sharp component of the QRS complex, b) the peak of
the QRS complex c) the end of the QRS complex (i.e. the J-point),
d) the peak of the T-wave and e) the end of the T-wave (figure 3).
These measurements were most consistent throughout the limb
leads. Electrical noise was apparent in a high proportion of chest
lead recordings during 3D mapping, results are thus presented
from limb lead measurements only. Measurements were repeated
3x and the median value used for comparisons. Values presented
represent the median value across the patient’s limb leads.
Intraclass correlation coefficients were 0.98 for intra-observer
variability and 0.96 for inter-observer variability of ECG
measures. Absolute measurements of surface ECG inscriptions
might be very sensitive to the patient-specific placement of the
pacing electrode, our analysis focused on measurements of change
from steady state pacing following premature stimuli (i.e.
hysteresis), guided by the observations of significant changes in
intracardiac activation and repolarization.
Statistical analyses
All statistical computing was performed in R software (R v
2.1.14, R Foundation for Statistical Computing, Vienna [26]).
Continuous parametric data are presented as mean6standard
deviation or, in the case of non-parametric data, median
[interquartile range], unless otherwise specified. Comparisons in
which a single measurement was taken for each subject
(ventricular effective refractory period, dispersion of repolarization
time, activation gradient (r2) and mean increase in delay) were
made using student’s t-test with correction for multiple compar-
isons. Continuous parametric data derived from electrogram data
were modeled using mixed-effects linear regression and statistical
significance was inferred from the model[27].
Mixed-effects logistical regression was used to construct
predictive models aiming to differentiate patient groups based on
electrogram data[28]. Data acquired from electrogram analysis
was added to a logistic regression models, resultant receiver-
operator curves (ROC) were generated and examined for
diagnostic ability. A mixed-effects logistic was created and
covariates removed in a stepwise manner to optimise model fit.
Mixed-effects modeling allowed individual-patient random factors
to be accounted for and included in calculations.
Recursive partitioning (a.k.a. classification and regression trees,
CART) was applied to surface ECG data to determine optimum
cut-offs attempting to distinguish ARVC from a mixed group of
patients. This is a decision-learning technique that enables optimal
splits in a group formed on different observations to occur[29].
Once a split is made, the same process in run on the child groups
until no further gains can be made (hence recursive). Discovery of
optimum decision strategies and cutoffs is rapid, and the outputs
Figure 2. Intracardiac signal analysis. Unipolar electrograms showing the three final activations following a S1S2 train are shown. Timings of
stimulus artifact are indicated by S1, S2. The moment of local activation (A) is taken as the steepest downsloping point of the electrogram complex (A0
– A2). Repolarisation time (RT) is calculated as the time from stimulus to activation. Local repolarization is taken as the most rapid upstroke of the
unipolar T-wave (R0 - R2) and repolarization time is calculated as the time from stimulus to local repolarization. The ARI is the time between activation
and repolarization. Diastolic interval was calculated as A1A2 – A0R0 (i.e. local activation interval minus the steady state ARI). AT: Activation Time, RT,
Repolarization Time, ARI: Activation Repolarisation Index.
doi:10.1371/journal.pone.0099125.g002
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are easily understandable and testable. A p value of ,0.05 was
regarded as statistically significant. The authors had full access to
and take full responsibility for the integrity of the data. All authors
have read and agree to the manuscript as written.
Results
Patient demographics
22 patients with definite (12 pts) or probable (10 pts) ARVC
were studied (mean age 46611 years)[11]. The patients had no
major structural features of ARVC with only 2 demonstrating
minor modified Task Force imaging criteria. Only 6 patients had
T wave inversion in leads V1-V3 and one a slurred S wave on
ECG. The signal averaged ECG was positive in 11 cases (5
mutation positive[14,30,31]). Twelve definite ARVC patients met
the criteria because of their mutation carrier/family history status
and therefore represent a group of patients with very early disease
preceding the development of diagnostic structural abnormalities.
Detailed demographic details are given in Table 1.
25 consecutive patients with monomophic ventricular ectopy
(965268444 beats/24 h), structural normal hearts and normal
resting ECGs underwent non-contact mapping and EP studies. 14
of these patients had .18 m follow-up with no recurrence of
ventricular ectopy off antiarrhythmic medication, and no features
suggestive of ARVC. These patients were analyzed as the RVOT
ectopy group (age 45614 years). Twelve further patients
undergoing electrophysiological studies 6 ablation for supraven-
tricular tachycardia with structurally normal hearts acted as
Normal controls (age 43618 years).
Intracardiac measurements
Sinus rhythm: activation and repolarization. No signifi-
cant differences in RV activation times, ARI or repolarization time
were observed between groups (Table 2).
Quantification of regional and local conduction
delay. Differences in slowest measured activation gradient (a
measure of slowest endocardial conduction in sinus rhythm)
between groups did not reach statistical significance, although
activation gradients in ARVC and RVOT ectopy groups were
20% lower than controls (definite ARVC 0.41617 mm/ms,
probable ARVC 0.41618 mm/ms, RVOT ectopy
0.40616 mm/ms, Normals 0.51613 mm/ms, all p.0.05). r2, a
measure of uniformity of conduction, was higher in both ARVC
groups and in normal controls than in the RVOT ectopy patients
(definite ARVC: 0.9460.07, probable ARVC 0.9460.05, RVOT
ectopy 0.8560.12, Normals:0.9460.07, p,0.05 vs RVOT
ectopy). There were no differences between either of the ARVC
or normal control groups.
Steady state pacing: activation and repolarization. In
steady state pacing, RV activation took significantly longer in
probable ARVC patients than in RVOT ectopy subjects
(98622 ms vs 77622 ms, p = 0.01), but this did not reach
statistical significance in the definite ARVC group (91621 ms)
or normal controls (94628 ms). There was a trend to longer
repolarization times in the ARVC groups when compared to the
RVOT ectopy group (definite ARVC: 308619 p= 0.07, probable
ARVC: 307616 ms p= 0.05, RVOT ectopy: 299632 ms), but no
group was significantly different from normal (303642 ms).
Premature extrastimuli: activation and repolariza-
tion. Examples of restitution curves are illustrated in Figure
S1. Ventricular effective refractory periods (VERPs) were similar
Figure 3. Paced ECG analysis. The final three paced limb-lead ECG complexes following a S1S2 train are shown, with the measurements taken
marked. Stim: Stimulus.
doi:10.1371/journal.pone.0099125.g003
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across groups. Activation times were increased more in the definite
ARVC patients at S1S2 coupling intervals just longer than VERP
(pre-VERP) than in other groups (increase in activation time:
definite ARVC 48612 ms, probable ARVC 37621 ms, RVOT
ectopy 34614 ms, Normal 26616 ms, p,0.001, Figure 4a). The
absolute activation time pre-VERP was also longer in definite
ARVC patients than in RVOT ectopy patients (definite ARVC:
123630 ms, 116635 ms, RVOT ectopy 92628 ms, p,0.001
(Figure 4b). There was a trend towards longer absolute activation
times in ARVC pre-VERP when compared to Normal controls
(104633 ms, p = 0.1).
The activation delay curves were plotted for each electrode in
every patient. Mean increase in delay, a measure of cumulative
delay in activation times over all coupling intervals, were greater in
the ARVC patients (definite ARVC: Median 7.0 [Interquartile
range 3.6–9.3] vs 3.1 [0–5.1] ms2, probable ARVC: 6.3 [3.3–9.5]
ms2) than in RVOT ectopy patients (4.3 [1.4–7.1] ms2, p,0.01) or
Normal controls (3.4 [0–5.2] ms2, p,0.001).
Repolarisation times were compared in a similar manner. The
change in repolarisation time pre-VERP compared to steady state
was +15630 ms in the definite ARVC group, whereas it was
shorter in other groups (probable ARVC +1619 ms, RVOT
ectopy -2623 ms p= 0.01, Normal27622 ms p,0.01)(Figure 5).
ARI restitution slopes. The maximum slopes of ARI
restitution curves were marginally steeper in the probable ARVC
and RVOT groups compared to normal, but there was no
statistically significant difference between the definite ARVC
group and any other group (definite ARVC: 0.7760.40, probable
ARVC: 0.8760.48, RVOT ectopy: 0.83641, Normal:
0.6860.41; p,0.05). There were no significant differences in the
odds ratio of having a maximum ARI restitution slope of .1 in
any segment between patient groups.
Fractionated electrograms. In sinus rhythm, more frac-
tionation was observed in RVOT ectopy patients than in definite
or probable ARVC or normal controls. However, during pacing at
steady state, RVOT ectopy and both ARVC groups had more
fractionation than normal controls (Figures 6 & 7). At coupling
intervals approaching VERP, the RVOT ectopy group &
probable ARVC groups appeared more fractionated than the
definite ARVC group (p,0.05), which in turn remained more
fractionated than controls (p,0.001).
Logistic models and the paced-surface ECG
Single intracardiac electrophysiological predictors were gener-
ally poor at differentiating definite ARVC from RVOT ectopy,
but an increase in the local activation time of .47 ms at ERP
compared to in steady state pacing gave a sensitivity of 70% and a
specificity of 74% in predicting definite ARVC over RVOT
ectopy. A mixed-effects logistic regression model was created to
explore the predictive potential of combining intracardiac
variables. The resultant model has an area under the curve of
0.85 (Figure 8, Table 3) for differentiating definite ARVC and
RVOT ectopy groups indicating a good level of predictive
accuracy when changes in activation, repolarisation time and
fractionation parameters were included. We considered the
Table 2. Endocardial Conduction and Repolarization Parameters.
Normal RVOT Ectopy Definite ARVC Probable ARVC
n= 12 n = 14 n = 12 n = 10
Baseline Heart Rate 81617 92618 8569 94611
VERP 212623 210613 205616 214618
Sinus Activation Time (ms) 71619 76625 81619 80619
Sinus Repolarization Time (ms) 302644 311649 320640 317642*
Sinus ARI (ms) 230649 235644 239638 237638
Steady State AT (ms) 79629{ 58624* 75622{ 79628{
Steady State ARI (ms) 194625 201620 203623 204619
Steady State Repolarisation Time (ms) 273646 260632 278635 282639{
Mean AT pre-VERP (ms) 104633 92629 123630{{ 117635{
Mean ARI pre-VERP (ms) 161626 166626 170628 167626
Mean RT pre-VERP (ms) 265651 258644 293650{ 284652
Change in AT pre-VERP (ms) 26616 34614 48621***{ 38621*
Change in RT pre-VERP (ms) 27622 22622 15629*{ 1629
Maximum ARI Restitution Slope (ms) 0.6860.41 0.8360.41 0.7760.4 0.8760.48
Fractionation at pre-VERP 2.460.5 3.461.1 361*{ 3.161.1
Fractionation in Steady State 2.560.6 3.460.9 3.161.1* 3.361*
Fractionation in Sinus Rhythm 361.4 3.4461.66 2.8461.31{ 2.9161.1{
Mean Increase In Delay 3.7610.3 4.165.6 6.565.6*{ 7.4615.4
Significance codes:
* p,0.05 vs Normals.
** p,0.01 vs Normals.
***p,0.0001 vs Normals.
{p,0.05 vs RVOT Ectopy.
{{p,0.01 vs RVOT Ectopy.
Note: Activation and Repolarization times are given as means6SD for all measurements throughout ventricle.
HR: Heart Rate, ERP: effective refractory period, ARI: Activation Recovery Index, AT: Activation Time, RT: Repolarization Time.
doi:10.1371/journal.pone.0099125.t002
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intracardiac mapping protocol too complex to recommend as a
practical clinical test however, and sought simpler markers that
may be of diagnostic value. We therefore examined the surface
ECG for discriminators analogous to our intracardiac measure-
ments.
Absolute surface ECG measurements of activation and repo-
larization did not distinguish between RVOT ectopy and ARVC
groups at baseline and pre-VERP. However, significant differences
in paced ECG parameters were identified (Figure 9 & 10A,
Table 4). A greater increase in activation time at ERP by
36613%compared to steady-state was observed in the definite
ARVC group than in the other groups (probable ARVC 21610%,
Normal 21611%, RVOT ectopy 17616%, figure 8B), measured
as an increase in time from pacing artifact to QRS onset (latency),
pacing artifact to nadir of S wave and pacing artifact to end of
QRS complex (J-point). No significant change was observed in
other groups. Application of the model to the combined probable/
definite group gave an AUC of 0.73 (p,0.001) and optimal
sensitivity and specificity of 65% and 67%.
Time from pacing artifact to the end of the T-wave was used as
a surrogate marker of complete repolarization of the ventricles.
This interval increased in definite ARVC patients more than in
either RVOT ectopy patients or the probable ARVC group.
Diagnostic utility of paced ECG changes (CART analysis)
(Figures 7 & 8)
A prolongation in the time from the pacing artifact to the end of
the QRS complex of .48 ms (pre-VERP minus steady state) gave
a sensitivity of 67% and specificity of 88% in the diagnosis of
definite ARVC (figure 10). A reduction in QRS duration of -6 ms
or less was insensitive (sensitivity 50%) but specific (specificity 85%)
for RVOT ectopy. Further partitioning based on a shortening in
the time from stimulus to the peak of the T-wave of greater than -
11 ms distinguished possible ARVC and normal groups, with
sensitivity and specificity at distinguishing these two groups from
one another of 71% and 59% respectively.
Discussion
This is the first study to compare differences in conduction and
repolarization kinetics in an ARVC population with earlier disease
than customarily reported with benign RVOT ectopy cases. The
key findings include: 1) Marked conduction delay in patients with
early ARVC when pacing at short coupling intervals, which was
not evident in sinus rhythm. This exists on a spectrum, with
definite ARVC exhibiting more conduction delay than probable
ARVC patients compared to normals. 2), Progressively longer
local repolarization times as coupling intervals decrease towards
Figure 4. Dynamic changes in activation time. A. Example 3D colormaps showing activation times in steady state and pre-VERP. The change in
activation delay in ARVC patients is greater than in Normal Controls & RVOT Ectopy (RVOTE) patients. Color scale represents local activation time
relative to pacing stimulus. B. Notched box plot of change in activation times from steady state to ERP. Values are normalized to steady state. Notches
indicate approx. 95% confidence intervals.
doi:10.1371/journal.pone.0099125.g004
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VERP in definite ARVC patients versus normal controls &
RVOT ectopy subjects. 3) Marked differences in fractionation at
short coupling intervals pre-VERP throughout the right ventricle
between patient groups, with more fractionation in both ARVC
and RVOT ectopy patients. 4) Surface ECG biomarkers of
conduction/repolarization dynamics provide diagnostic informa-
tion - an increase in the time from pacing stimulus to full
ventricular activation (defined as the end of the QRS complex i.e.
the ‘‘J-point’’) of greater than 48 ms gave an 88% specificity and
68% sensitivity of distinguishing definite ARVC from other
groups.
Previous clinical studies have demonstrated electrophysiological
abnormalities in established ARVC with significant structural
disease, including prolonged RV activation times in sinus rhythm
and low endocardial bipolar electrogram voltages [9,32]. Howev-
er, this has not been validated for the clinical differentiation of
benign RVOT ectopy or VT from early ARVC. At least 40%
fibro-fatty replacement is required before detectable attenuation of
endocardial voltages occurs and thus disease expression in the
early, concealed phase is missed [32,33]. Although 12 lead ECG
anomalies may precede structural changes, these can be transient
or non-specific [34]. The problem of recognising early ARVC is
reflected in recent amendments to the consensus diagnostic
criteria, which highlight the increasing importance of familial
disease and genetic markers so that a definite diagnosis can be
made utilizing genetic status or a family history of the disease [11].
This means the diagnosis can be made in the absence of obvious
structural disease. Early recognition of disease has potentially
important management implications; including avoidance of
exercise training, ICD prophylaxis and targeted family screening.
An earlier study of desmoplakin mutation carriers demonstrated
that these patients have significantly greater mean increases in
delay during an S1-S2 restitution protocol, particularly in the
outflow tract compared to SVT controls[6].The question arose as
to whether these changes in conduction and repolarization
dynamics are a universal feature of ARVC. This would be
consistent with pre-clinical studies implying arrhythmia mecha-
nisms independent of defined scar. If so, these criteria could be
utilised to differentiate benign RVOT tachycardia from concealed
ARVC. We therefore investigated cases with little or no imaging
abnormalities plus patients classed as borderline ARVC using
updated consensus criteria.
Our observation of an increase in induced conduction slowing
with premature extrastimuli can be regarded as evidence of a lack
of conduction reserve. This is consistent with data implying a
sodium current deficit in murine models of ARVC [4,7,35], and
cross-over between Brugada syndrome and ARVC in the
mechanisms of arrhythmia [5].
Figure 5. Dynamic changes in repolarization time. A. Loess regression plots of Absolute Repolarisation times within the right ventricle are
shown, plotted against coupling interval. There is a marked increase in repolarization times throughout the ventricle at short coupling intervals in the
definite ARVC group compared to other groups. B. Change in repolarization time at ERP compared to steady state. There is a significantly greater
change in definite ARVC groups than in other groups.
doi:10.1371/journal.pone.0099125.g005
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Importantly, it was primarily the family history of ARVC or
mutation carrier status that allocated these patients to the
‘‘Definite ARVC’’ group in our study. In the absence of gene
testing, 4/12 of the definite ARVC cases would be regarded as
borderline. This implies that in a population of combined
probable and definite cases the predictive accuracy of this
partitioning method may be increased. Indeed, when both groups
are combined, the classification tree was able to distinguish any
Figure 6. Global fractionation. Panel A shows a notched boxplot of global mean fractionation index. Fractionation is significantly increased in
RVOT ectopy and ARVC patients compared to normals. Panel B shows example electrograms (light grey) and their mathematical differentials, from
which fractionation index (FI) was calculated. Panel C shows three example colormaps of distribution of fractionation. Higher levels of fractionation
are seen in both RVOT ectopy (RVOTE) and ARVC.
doi:10.1371/journal.pone.0099125.g006
Figure 7. 3D color maps of fractionation measured pre-ERP-distribution in Normal individuals, RVOTE and definite ARVC. There is a
patchy distribution of fractionated electrograms in both RVOTE and in ARVC ventricles.
doi:10.1371/journal.pone.0099125.g007
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ARVC patient from a combined group of RVOT/Normals with a
sensitivity of 67% and specificity of 84%.
We can speculate why a disparity may exist in the degree of
induced activation delays between these two groups. Six patients
in the definite ARVC group exhibited a surface 12-lead ECG
feature of disease at rest, versus none in the probable ARVC group
(Table 1). Lack of conduction reserve would both become more
apparent during the pacing protocol and unmask features seen on
the 12-lead ECG. Both the demographic data and mapping results
imply that the electrical phenotype in our definite ARVC patients
was more severe than in probable ARVC patients.
Even the patients with more advanced disease did not
demonstrate global RV activation delays in sinus rhythm, but it
was more marked at short coupling intervals during RV pacing.
The dynamics of repolarization were also significantly affected,
amplifying effects of conduction delay in ARVC and creating
significantly more prolonged repolarization times pre-VERP than
steady state versus controls and RVOT ectopy patients. Digital
examination of the signal averaged ECG may yet reveal previously
hidden features of conduction delay in these patients, but this fell
outside of the scope of this study.
Figure 8. Receiver-operator characteristic (ROC) curves derived from logistic models of electrophysiological criteria. ROC curves are
shown for the individual determinants of the most predictive model for definite ARVC derived from electrogram data. AT: Activation time, VERP:
Ventricular effective refractory period, Repol Time: Repolarisation Time.
doi:10.1371/journal.pone.0099125.g008
Table 3. Mixed Effects Logistic Regression Model coefficients.
Estimate Std. Error z p
Random Effects
Location 0.2660.51
Fixed Effects
(Intercept) 3.57 0.78 4.57 ,0.0001
Change in AT pre-VERP 20.03 0.01 25.83 ,0.0001
Fractionation in Sinus Rhythm 0.37 0.06 6.11 ,0.0001
Fractionation at VERP 0.40 0.08 4.76 ,0.0001
Repolarization time in Sinus Rhythm 20.01 0.00 23.12 ,0.001
Steady State AT 20.05 0.00 210.1 ,0.0001
doi:10.1371/journal.pone.0099125.t003
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The partitioning tests identified stimulus to T-wave peak
interval as a potential distinguishing feature between normal and
probable ARVC patients. This measure reflects a composite of
activation and repolarisation phenomena, and could be seen as a
surface ECG marker of the intracardiac repolarisation time
changes observed (figure 5).
Endocardial electrophysiological changes in RVOT ectopy
Two phenomena were observed in the RVOT ectopy patients:
consistently shorter repolarisation times versus supraventricular
tachycardia patients and ARVC, cases and increased fractionation
compared to control cases. The shorter repolarisation times may
reflect a memory phenomenon induced by the high ventricular
ectopic burden. A shortening in ARI occurs and with it a
reduction in refractory period, thus allowing local myocytes to be
more susceptible to activation. The high degree of fractionation in
benign RVOT ectopy patients similar to that seen in ARVC also
deserves comment. Conduction delay and fractionation occurs in
ARVC due to fibrofatty replacement and/or dissociation of
preferentially conducting myocardial pathways through reduced
gap junction coupling and Na channel downregulation [4-
6,35,36]. However, the conduction delays measured in benign
RVOT ectopy patients were indistinguishable from normal hearts,
yet significantly more fractionation existed. A single plane of
fibroblasts could explain this by facilitating ectopic formation
through source-sink mismatching & fractionation in one direction
of activation, but preserving conduction in another [37,38]. This
hypothesis could be tested using differential pacing in a future
study. In the ARVC patients, higher r2 values indicating
uniformity of conduction were observed compared to RVOT
ectopy cases. Similarly, we have reported more uniform conduc-
tion in Brugada Syndrome versus controls [17] suggesting that
diseases that promote dissociation of the myocardial layers
whether due to structural or ion channel differences reduce the
contribution of activation from the Purkinje network breaking
through the endocardium to allow more homogeneous &
consistent endocardial activation & wavefront propagation.
Taken together, features of conduction delay, increased
repolarization times and mild fractionation at short coupling
intervals pre-VERP would support a diagnosis of early ARVC
over that of a benign RVOT ectopy, with a logistic model
demonstrating a positive predictive value of 80% from the
presented data. These differences can also be identified simply
using paced-QRS-T-wave parameters.
This study confirms that reduced conduction reserve develops
early in ARVC before detectable structural RV changes on
conventional imaging ensue. This has important implications since
sudden cardiac death can occur in patients with minimal
histological changes in the sub-clinical phase of ARVC and thus
a more sophisticated clinical evaluation using dynamic conduc-
tion-repolarization changes is required [3]. In a recent study, a
positive signal averaged ECG correlated with the size of reduced
Figure 9. Typical ECG examples of J-point hysteresis. Three representative paced ECGs are shown with stimulus to J-point timings of steady
state and pre-VERP beats. The ARVC patient has a markedly extended J-point hysteresis pre-VERP than either normal patient or the RVOT ectopy
patient.
doi:10.1371/journal.pone.0099125.g009
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endocardial voltage regions and histological evidence of cardiomyo-
pathic disease but had a low sensitivity; 21% cases studied still had
evidence of major RV structural abnormalities on imaging, indicating
that static surface ECGmarkers may be too insensitive in the concealed
phase [39]. In a study examining ventricular ectopic morphology in
ARVC, the extent of structural disease was not described [40]. This
study illustrates that dynamic surface ECG conduction-repolarization
parameters may be of diagnostic value in early disease.
Study limitations
The human mapping technique evaluates endocardial electro-
physiology and thus mid-myocardial and epicardial effects of
ARVC could not be assessed. This is important since structural
changes manifest epicardially prior to progressing endocardially
[40]. Although differences in myocardial electrophysiology between
benign RVOT ectopy patients followed for .18 months post
ablation and ARVCwere identified, a prospective long-term follow-
up study of this patient cohort would be required to confirm these
observations. As with any novel disease marker, validation in a de
novo population will be required for an impartial assessment of the
diagnostic utility of paced J-point hysteresis. Logistical regression
models can highlight the differences between groups in this study,
but cannot be taken as a diagnostic test based on the data presented.
The probable ARVC group still represents a diagnostic
dilemma as a gold standard test is lacking, yet our data has
important pathophysiological implications for the understanding
of the development of arrhythmias in this population. Disease
progression in increasingly understood as initially an epicardial
phenomenon, we were not able to examine epicardial effects with
our mapping or pacing strategy. Non-contact mapping may be
insensitive at identifying low-voltage fractionation in small areas.
Conclusions
Early ARVC exhibits greater conduction delay and dispersion
of repolarization, particularly at short coupling intervals, than
either normal hearts or benign RVOT ectopy. Fractionation is
mildly increased in early ARVC, but also significantly in benign
RVOT ectopy. The dynamic differences in conduction, repolar-
ization and fractionation are manifest on the surface paced ECG
& could help refine the early identification of early concealed
ARVC patients from those with benign outflow tract ectopy.
Figure 10. CART analysis. Panel A shows the optimum recursive partition tree. An increase in the time from the stimulus to the end of the paced
QRS complex (J-point) of.48 ms gave a sensitivity of 67% and specificity of 88% for definite ARVC. B and C show raw data for the principal branches.
These measurements were able to distinguish any ARVC patient from RVOT ectopy (RVOTE)/Normal patients with a sensitivity of 67% and specificity
of 84%.
doi:10.1371/journal.pone.0099125.g010
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Supporting Information
Figure S1 Examples of restitution curves from a patient
with ARVC and from a normal control. Repolarisation time,
ARI and activation time are plotted against coupling interval.
Points represent means of four repeated measurements. Early
activated sites are shown in red, late in blue.
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